Possible enhancement of the cardiotoxicity of doxorubicin when combined with mitomycin C
- 1 June 1985
- journal article
- research article
- Published by Springer Nature in Medical Oncology and Tumor Pharmacotherapy
- Vol. 2 (2) , 93-97
- https://doi.org/10.1007/bf02934854
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Doxorubicin Cardiotoxicity and MelphalanAnnals of Internal Medicine, 1981
- 5-Fluorouracil, Doxorubicin, and Mitomycin (FAM) Combination Chemotherapy for Advanced Gastric CancerAnnals of Internal Medicine, 1980
- Risk Factors for Doxorubicin-lnduced Congestive Heart FailureAnnals of Internal Medicine, 1979
- Adriamycin cardiotoxicity in stage IV breast cancer: Possible enhancement with prior left chest radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Doxorubicin Cardiomyopathy: Evaluation by Phonocardiography, Endomyocardial Biopsy, and Cardiac CatheterizationAnnals of Internal Medicine, 1978
- Relationships between mean velocity of circumferential fiber shortening (VCF) and heartrate - the diagnostic value of a normalization of VCF to heart rateJournal of Clinical Ultrasound, 1978
- Electrocardiographic changes following adriamycin treatmentMedical and Pediatric Oncology, 1978
- Mitomycin C: a reviewCancer Treatment Reviews, 1976
- Cardiac effects of doxorubicin therapy of neoplasmsPublished by American Medical Association (AMA) ,1976
- Adriamycin and Radiation: Synergistic CardiotoxicityAnnals of Internal Medicine, 1975